India, Oct. 19 -- The Thane-based active pharmaceutical ingredient and formulations maker has delivered a quarter where sales and profit both grew at double-digit rates, helped by stronger overseas demand and a rebound in branded drugs. A regulatory first and a stronger credit profile add momentum, though cash flow and rising debt warrant attention. The Nifty 50 traded at 22888.95, down 1.11%, while the Sensex fell 1.17% to 73,852.90 on Monday. Following this, the Shares of Bajaj Healthcare Ltd are closed at Rs. 338.50, down 0.76 percent on Monday. The stock touched the intraday high of Rs. 351.00 after opening at Rs. 345.00 before slipping to a low of Rs. 323.95. The company commands a market capitalization of Rs. 1,139.57 crore.

Profi...